生物制剂在喘治疗效果的时间变化:通过改变患者特征来修改效果
Tanawin Nopsopon1, Alyson Brown1, Georg Hahn2
1Division of Allergy and Clinical Immunology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Respiratory medicine
|September 11, 2024
概括
像奥马利祖马布这样的喘生物学药物的有效性随着时间的推移而变化,受患者选择和新治疗方法的引入的影响. 这种时间变化会影响治疗结果,特别是对奥马利祖马布.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 呼吸单克隆抗体的患者人群可能随着新的生物批准而演变.
- 了解时间有效性对于优化严重喘管理至关重要.
研究的目的:
- 评估日历时间如何改变喘患者呼吸系统生物药物的有效性.
- 分析连续生物批准对治疗疗效的影响.
主要方法:
- 重症喘患者 (2013-2023) 的回顾性队列研究 (呼吸系统生物制剂在喘中的有效性 - ERA).
- 分析喘相关的恶化,比较使用Poisson和Cox回归的治疗前和治疗后的启动期.
- 根据治疗时代的分层:抗IgE,抗IL5,抗IL4/13和抗警报.
主要成果:
- 与初始时代相比 (IRR 1.16 [0.94-1.43]),奥马利祖马布的有效性在后期时代增加 (IRR 0.54 [0.37-0.80]) ,与较低的乙氨基和较少的CRSwNP相关.
- 抗IL5和dupilumab在抗IL4/13时代表现出高峰的有效性 (IRR分别为0.52 [0.42-0.64]和0.60 [0.50-0.72]).
- 在生物药物中观察到时间效果的变化,受患者特征 (如BMI和吸烟状况) 的影响.
结论:
- 严重喘的生物有效性表现出时间变化,部分原因是治疗患者群体的变化.
- 随着时间的推移,改善的患者选择提高了奥马利祖马布的有效性,但这种趋势对于其他生物药物来说不那么一致.
- 生物疗法的不断变化需要对现实世界的有效性进行持续评估.
相关概念视频
01:19Antiasthma Drugs: Leukotriene Modifiers
253
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
253
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
246
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
246
01:19Factors Affecting Drug Biotransformation: Biological
125
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
125
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
48
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
48
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
239
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
239
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K